What will be the basis for amending the US regulatory framework
The data obtained in the course of research by two reputable research centers will form the basis of decisions of state structures , which, based on them, will be able to determine which changes to the current regulatory framework should be made based on the most effective use of the therapeutic properties of the plant for the treatment of patients in need. 
Leading American researchers will test the effectiveness of the therapeutic properties of extracts of individual cannabinoids compared to full-spectrum extracts , as well as unextracted plant materials containing dozens of hemp plant elements with tremendous therapeutic properties ( terpenes, cannabinoids, finols, flavonoids, terpenoids, etc. ), using the so-called “ ensemble effect ” to enhance their properties . This study, worth $ 9 million, is not only aimed at determining the effectiveness of variousmethods of using the therapeutic properties of hemp , but also to educate medical personnel, as well as potential consumers, in the effective use of the natural properties incorporated in hemp plant for the treatment of a number of serious, including chorionic diseases .
Harvard Medical School (the Harvard Medical School ), which will lead the research project , and the Massachusetts Institute of Technology Institute (Massachusetts You will Institute of Technology) received $ 4.5 million for the provision of a series of related studies . The grant, which is the largest in the history of hemp research , was provided by Charles R. Broderick (one of the first investors in the Canadian medical cannabis market ), who is a graduate of both of the above educational institutions . According to Mr. Broderick, “The study is aimed not only at destagmatizing the therapeutic properties of hemp , but also providing reliable information to the medical community and the general public , which will form the basis for further methods of using the plant for medical purposes . The scientific community needs to provide enough data for their work , and not each time refer to the fact that the available information is not enough to carry out the treatment , using the exclusive therapeutic properties of hemp . ”
According lecturer Psychiatry Harvard Stacey Gruber, which manages the corresponding research program in the course of the experiments will examine the effects of various extracts beznarkoticheskih cannabinoids ( primarily cannabidiol ), extracts the full range (which structure includes tens therapeutically active cannabis substances ), and green mass of the plant for patients suffering from various types of diseases. According to Ms. Gruber, “Our research can clarify the potential for synergistic effects that arise when using full spectrum extracts or untreated green mass as compared to single extracted compounds.”
According to experts from the research group , “Conducting such experiments is extremely important. Determining the effectiveness of the use of extracts of individual cannabinoids in comparison with the action of extracts of the full spectrum or hemp leaves and inflorescences for the treatment of specific diseases, not only increases the effectiveness of treatment, but also reduces the possible harm from the use of techniques involving serious side effects. Along with informing consumers and the medical staff about the effectiveness of using those or other techniques , the results will be used to make changes to the legal framework regulating the possibility of using those or other methods of using cannabis preparations , have significant therapeutic properties .
Commentary experts of the Association " Ukrainian industrial hemp "
During the round tables “ Use of cannabinoids in the treatment of severe / chronic diseases ”, “ Nutrition and hemp ”, “ Cannabinoid therapy ” conducted within the framework of the “ Hemp University ” by Ukrainian specialists working in the field of application of therapeutic properties of hemp, it was constantly emphasized that the effect of The effects of therapeutic therapeutic hemp leaves and inflorescences on patients during treatment of severe diseases including chronic ones are significantly higher than the use of extracts of individual cannabinoids . Extremely useful for the Ukrainian hemp market is the fact that, unlike representatives of national pharmacological companies, lobbying primarily for their interests while promoting the need to use specifically patented drugs on the national market , in the United States the procedure for amending the legislative framework works exactly the opposite. The data obtained in the course of research by two reputable research centers will form the basis of decisions of state structures , which, based on them, will be able to determine which changes to the current regulatory framework should be made based on the most effective use of the therapeutic properties of the plant for the treatment of patients in need.